Sphingomyelin Synthase 1 (SMS1) Downregulation Is Associated With Sphingolipid Reprogramming and a Worse Prognosis in Melanoma

Sphingolipid (SL) metabolism alterations have been frequently reported in cancer including in melanoma, a bad-prognosis skin cancer. In normal cells, de novo synthesized ceramide is mainly converted to sphingomyelin (SM), the most abundant SL, by sphingomyelin synthase 1 (SMS1) and, albeit to a less...

全面介紹

Na minha lista:
書目詳細資料
發表在:Front Pharmacol
Main Authors: Bilal, Fatima, Montfort, Anne, Gilhodes, Julia, Garcia, Virginie, Riond, Joëlle, Carpentier, Stéphane, Filleron, Thomas, Colacios, Céline, Levade, Thierry, Daher, Ahmad, Meyer, Nicolas, Andrieu-Abadie, Nathalie, Ségui, Bruno
格式: Artigo
語言:Inglês
出版: Frontiers Media S.A. 2019
主題:
Pharmacology
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6503817/
https://ncbi.nlm.nih.gov/pubmed/31114500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.00443
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍